Loading...
Dignitana AB (publ)
DIZTF•PNK
Healthcare
Medical - Devices
$0.22
$0.00(0.00%)
Dignitana AB (publ) (DIZTF) Financial Performance & Income Statement Overview
Review Dignitana AB (publ)’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
4.38%
↑ 4.38%
Operating Income Growth
-21.76%
↓ 21.76%
Net Income Growth
-10.46%
↓ 10.46%
Operating Cash Flow Growth
106.49%
↑ 106.49%
Operating Margin
-16.51%
↓ 16.51%
Gross Margin
66.25%
↑ 66.25%
Net Profit Margin
-17.63%
↓ 17.63%
ROE
-222.31%
↓ 222.31%
ROIC
-209.00%
↓ 209.003%
Dignitana AB (publ) (DIZTF) Income Statement & Financial Overview
Review Dignitana AB (publ)'s (DIZTF) income statement with detailed quarterly and annual figures.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $23.97M | $22.85M | $21.84M | $21.16M |
| Cost of Revenue | $8.40M | $8.00M | $6.97M | $6.19M |
| Gross Profit | $15.57M | $14.85M | $14.87M | $14.98M |
| Gross Profit Ratio | $0.65 | $0.65 | $0.68 | $0.71 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
| SG&A Expenses | $0.00 | $0.00 | $21.84M | $15.84M |
| Operating Expenses | $17.16M | $15.58M | $25.89M | -$26.16M |
| Total Costs & Expenses | $25.56M | $23.58M | $32.87M | -$26.16M |
| Interest Income | $751000.00 | $93000.00 | $334000.00 | $546000.00 |
| Interest Expense | $247000.00 | $910000.00 | $765000.00 | $649000.00 |
| Depreciation & Amortization | $2.65M | $2.86M | $4.01M | $3.87M |
| EBITDA | $1.82M | $2.22M | -$6.68M | -$541000.00 |
| EBITDA Ratio | $0.08 | $0.10 | -$0.31 | -$0.03 |
| Operating Income | -$1.59M | -$730000.00 | -$10.98M | -$5.00M |
| Operating Income Ratio | -$0.07 | -$0.03 | -$0.50 | -$0.24 |
| Other Income/Expenses (Net) | $504000.00 | -$817000.00 | -$471000.00 | -$103000.00 |
| Income Before Tax | -$1.08M | -$1.55M | -$11.45M | -$5.06M |
| Income Before Tax Ratio | -$0.05 | -$0.07 | -$0.52 | -$0.24 |
| Income Tax Expense | $37000.00 | $0.00 | $0.00 | $5.06M |
| Net Income | -$1.12M | -$1.55M | -$11.45M | -$5.06M |
| Net Income Ratio | -$0.05 | -$0.07 | -$0.52 | -$0.24 |
| EPS | -$0.01 | -$0.02 | -$0.14 | -$0.07 |
| Diluted EPS | -$0.01 | -$0.02 | -$0.14 | -$0.07 |
| Weighted Avg Shares Outstanding | $80.54M | $80.54M | $79.44M | $70.47M |
| Weighted Avg Shares Outstanding (Diluted) | $80.54M | $80.54M | $79.44M | $70.47M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan